Related Experiment Video
Updated: May 30, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
A nonionic porphyrin as a noninterfering DNA antibacterial agent
Sónia Mendes1, Fábio Camacho, Tito Silva
1Faculdade de Engenharia, Universidade Católica Portuguesa, Rio de Mouro, Portugal.
A novel nonionic porphyrin, ACS769F4, shows promise for bacterial photodynamic inactivation. It effectively eradicates bacteria with minimal harm to mammalian cells, unlike a cationic porphyrin.
Area of Science:
- Photodynamic therapy
- Medicinal chemistry
- Bacteriology
Background:
- Clinical interest in bacterial photodynamic inactivation is growing.
- Need for photosensitizers with enhanced efficacy and reduced side effects.
- Existing photosensitizers like TTAP(4+) show toxicity to mammalian cells.
Purpose of the Study:
- To introduce and evaluate a novel nonionic porphyrin, ACS769F4, for bacterial photodynamic inactivation.
- To compare the efficacy and safety of ACS769F4 with a known tetracationic porphyrin, TTAP(4+).
- To assess the potential clinical applicability of ACS769F4.
Main Methods:
- Synthesis and characterization of the novel nonionic porphyrin ACS769F4.
- Photodynamic inactivation assays using Escherichia coli and Staphylococcus aureus.
- Cytotoxicity assays on human embryonic and baby hamster kidney cell lines.
- Microscopic examination of cellular effects, including nuclear accumulation and cytoskeleton integrity.
Main Results:
- ACS769F4 demonstrated bactericidal effects on E. coli and S. aureus via photodynamic inactivation.
- Higher concentrations of ACS769F4 were required compared to TTAP(4+) for bacterial eradication.
- ACS769F4 showed no adverse effects on mammalian cell viability or cytoskeleton, despite cellular accumulation.
- TTAP(4+) accumulated in the nucleus, induced chromatin condensation, and damaged the microtubule network in mammalian cells, even in the dark.
Conclusions:
- ACS769F4 exhibits significant bactericidal efficiency and a favorable safety profile for mammalian cells.
- Its nonionic nature and low toxicity make it a promising candidate for clinical evaluation in bacterial photodynamic inactivation.
- ACS769F4 warrants further investigation for potential therapeutic applications.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
DNA Bacteriophages
Inhibitors of Bacterial Protein Synthesis
Single-Strand DNA Binding Proteins
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling

